In particular, in people with ASCVD who have already well-controlled, established cardiovascular risk factors, Lp(a) remains to be an important determinant of residual cardiovascular risk, since for every combination of cardiovascular risk factors, elevated Lp(a) levels further increase the risk for future events [9,10]. Here, LPA is linked to atherosclerosis.